Amgen/Immunex cleared by FTC
Friday, 19 July 2002
Amgen, the world’s largest biotechnology company, has this week been given clearance by the Federal Trade Commission for its acquisition of Immunex, the Seattle-based biotechnology company.
Amgen and Immunex announced the deal last December.
PREMIUM Subscription required to view this article
This content can only be accessed by PREMIUM GCR subscribers.
A premium subscription includes 10 issues of the journal, 2 signature surveys - The GCR100 and Rating Enforcement, 10 GCR special reports and full access to current and archived print & online content.
If you are a GCR subscriber, please login to access this content:
Comments
You must Subscribe or Log In to make comments.
Comment Terms & Conditions
Back to top